To ascertain whether the dawn phenomenon occurs in nondiabetic individuals and, if so, whether it is due to an increase in glucose production or a decrease in glucose utilization, we determined plasma concentrations of glucose, insulin, C-peptide, and counter regulatory hormones, as well as rates of glucose production, glucose utilization, and insulin secretion at one-halfhourly intervals between 1:00 and 9:00 a.m. in eight normal volunteers. After 5:30 a.m., plasma glucose, insulin, and C-peptide concentrations all increased significantly; rates of glucose production, glucose utilization, and insulin secretion also increased (all P < 0.05). Plasma cortisol, epinephrine, and norepinephrine increased significantly from nocturnal nadirs between 4:00 and 6:30 a.m. Plasma growth hormone, which had increased episodically between 1:00 and 4:30 a.m., decreased thereafter nearly 50% (P < 0.05). Plasma glucagon did not change significantly throughout the period of observation. These results indicate that a dawn-like phenomenon, initiated by an increase in glucose production, occurs in nondiabetic individuals. Thus, early morning increases in plasma glucose concentrations and insulin requirements observed in IDDM and NIDDM may be an exaggeration of a physiologic circadian variation in hepatic insulin sensitivity induced by antecedent changes in catecholamine and/or growth hormone secretion.
Demonstration of a Dawn Phenomenon in Normal Human Volunteers
- Views Icon Views
- PDF LinkPDF
- Share Icon Share
Geremia B Bolli, Pierpaolo De Feo, Salvatore De Cosmo, Gabriele Perriello, Mariarosa M Ventura, Filippo Calcinaro, Claudio Lolli, Peter Campbell, Paolo Brunetti, John E Gerich; Demonstration of a Dawn Phenomenon in Normal Human Volunteers. Diabetes 1 December 1984; 33 (12): 1150–1153. https://doi.org/10.2337/diab.33.12.1150
Download citation file: